TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 5 33-5, 1996, Pages

  Sakurai, Yoichi ^b   Zhang, Xiao Jun ^b   Wolfe, Arobert R ^b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b NONE

Author keywords

free fatty acid; radioisotope; somatostatin; stable isotopes; substrate kinetics; tumor necrosis factor; ketoisocaproic acid

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; LEUCINE; LIPID; PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ARTICLE; DOG; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; LIPID METABOLISM; LIPOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM;

EID: 0029977403     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.5.e864     Document Type: Article

References (36)

1. Bagby, G. J., C. H. Lang, D. M. Hargrove, J. J. Thompson, L. A. Wilson, and J. J. Spitzer. Glucose kinetics in rats infused with endotoxin-indueed monokines or tumor necrosis factor. Cire. Shock 24: 111-121, 1988.
2. Bessey, P. Q., J. M. Watters, T. T. Aoki, and D. W. Wilmore. Combined hormonal infusion simulates the metabolic response to injury. Ann. Surg. 200: 264-281, 1984.
3. Cherrington, A. D., M. D. Caldwell, M. R. Dietz, J. H. Exton, and O. B. Crofford. The effect of somatostatin on glucose uptake and production by rat tissues in vitro. Diabetes 26: 740-748, 1977.
4. Cornelius, P., M. D. Lee, M. Marlowe, and P. H. Pekala. Monokine regulation of glucose transporter mRNA in L6 myotubes. Biochem. Biophys. Res. Commun. 165: 429-436, 1986.
5. Evans, D. A., D. O. Jacobs, and D. W. Wilmore. Tumor necrosis factor enhances glucose uptake by peripheral tissues. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26): R1182-R1189, 1989.
6. Hartl, W. H., H. Miyoshi, F. Jahoor, S. Klein, D. Elahi, and R. R, Wolfe. Bradykinin attenuates glucagon-induced leucine oxidation in humans. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E239-E245, 1990.
7. Hesse, D. G., K. J. Tracey, Y. Fong, K. R. Manogue, M. A. Palladino, Jr., A. Cerami, G. T. Shires, and S. F. Lowry. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166: 147-153, 1988.
8. Jahoor, F., D. N. Herndon, and R. R. Wolfe. Role of insulin and glucagon in the response of glucose and alanine kinetics in burn-injured patients. J. Clin. Invest. 78: 807-814, 1986.
9. Jahoor, F., R. E. Shangraw, H. Miyoshi, H. Wallfish, D. N. Herndon, and R. R. Wolfe. Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Am. J. Physiol. 257 (Endocrinol. Metab. 20): E323-E331, 1989.
10. 2 production during substrate oxidation studies. Am. J. Physiol. 257 (Endocrinol. Metab. 20): E296-E298, 1989.
11. Lee, M. D., A. Zentella, P. H. Pekala, and A. Cerami. Effect of endotoxin-indueed monokines on glucose metabolism in the muscle cell line L6. Proc. Natl. Acad. Sci. USA 84: 2590-2594, 1987.
12. Marano, M. A., L. L. Moldawer, Y. Fong, H. Wei, J. Minei, R. Yurt, A. Cerami, and S. F. Lowry. Cachectin/TNF production in experimental burns and Pseudomonas infection. Arch. Surg. 123: 1383-1388, 1988.
13. Michie, H. R., D. R. Spriggs, K. R. Manogue, M. L. Sberman, A. Revhaug, S. T. O'Dwyer, K. Arthur, C. A. Dinarello, A. Cerami, S. M. Wolff, D. W. Kufe, and D. W. Wilmore. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104: 280-286, 1988.
14. Miyoshi, H., G. I. Shulman, E. J. Peters, M. H. Wolfe, D. Elahi, and R. R. Wolfe. Hormonal control of substrate cycling in humans. J. Clin. Invest. 81: 1545-1555, 1988.
15. Nawabi, M. D., K. P. Block, M. C. Chakrabarti, and M. G. Buse. Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain α-keto acid dehydrogenase. J. Clin. Invest. 85: 256-263, 1990.
16. Offner, F., J. Philippe, D. Vogelaers, F. Colardyn, G. Baele, M. Baudrihaye, A. Vermeulen, and G. Leroux Roels. Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J. Lab. Clin. Med. 116: 100-105, 1990.
17. Rofe, A. M., R. A. J. Conyers, R. Bais, J. R. Gamble, and M. A. Vadas. The effect of recombinant tumor necrosis factor (cachectin) on metabolism in isolated rat adipocyte, hepatocyte and muscle preparation. Biochem. J. 247: 789-792, 1987.
18. Ronnjn, J. A., E. F. Coyle, L. S. Sidossis, A. Gastaldelli, J. F. Horowitz, E. Endert, and R. R. Wolfe. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E380-E391, 1993.
19. Rosenblatt, J., D. Chinkes, M. Wolfe, and R. R. Wolfe. Stable isotope tracer analysis by GC-MS, including quantification of isotopomer effects. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E584-E596, 1992.
20. Sakurai, Y., X. Zhang, and R. R. Wolfe. Short-term effects of tumor necrosis factor on substrate and energy metabolism in dogs. J. Clin. Invest 91: 2437-2445, 1993.
21. Sakurai, Y., X.-J. Zhang, and R. R. Wolfe. Effect of tumor necrosis factor on substrate and amino acid kinetics in conscious dogs. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E936-E945, 1994.
22. Shangraw, R. E., F. Jahoor, H. Miyoshi, W. A. Neff, C. A. Stuart, D. N. Herndon, and R. R. Wolfe. Differentiation between septic and poatburn insulin resistance. Metab. Clin. Exp. 38: 983-989, 1989.
23. Simmons, P. S., J. M. Miles, J. E. Gerich, and M. W. Raymond. Increased proteolysis: an effect of increases in plasma cortisol within the physiologic range. J. Clin. Invest. 73: 412-420, 1984.
24. Steele, R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann. NY Acad. Sci. 82: 420-430, 1959.
25. Stovroff, M. C., D. L. Fraker, and J. A. Norton. Cachectin activity in the serum of cachectic, tumor-bearing rats. Arch. Surg. 124: 94-99, 1989.
26. Van del Poll, T., J. A. Romijn, E. Endert, J. J. J. Borm, H. R. Büller, and H. P. Sauerwein. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am. J. Physiol. 261 (Endocrinol. Metab. 24): E457-E465, 1991.
27. Verdonk, C. A., R. A. Rizza, and J. E. Gerich. Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes 30: 535-537, 1981.
28. Waterlow, J. C., R. J. Garlick, and D. J. Millward. Protein Turnover in Mammalian Tissues and in the Whole Body. Amsterdam: North-Holland, 1978, p. 225-300.
29. Wilmore, D. W., A. D. Mason, Jr., and B. A. Pruitt. Insulin response to glucose in hypermetabolic burn patients. Ann. Surg. 183: 314-320, 1976.
30. Wilson, C. M. and S. W. Cushman. Insulin stimulation of glucose transport activity in rat skeletal muscle: increase in cell surface GLUT4 as assessed by photolabelling. Biochem. J. 299: 755-759, 1994.
31. Wolfe, R. R. Substrate kinetics in sepsis. In: The Scientific Basis for the Care of the Critically III, edited by K. N. Frayn and R. A. Little. Manchester, UK: Manchester Univ. Press, 1986, p. 123-151.
32. Wolfe, R. R. Radioactive and Stable Isotope Tracers in Bwmedicine. Principles and Practice of Kinetic Analysis. New York: Wiley-Liss, 1992.
33. Wolfe, R. R., M. J. Durkot, and M. H. Wolfe. Investigation of kinetics of integrated metabolic response to adrenergic blockade in conscious dogs. Am. J. Physiol. 241 (Endocrinol. Metab. 4): E385-E395, 1981.
34. Wolfe, R. R., E. J. Peters, S. Klein, O. B. Holland, J. Rosenblatt, and H. Gary, Jr. Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am. J. Physiol. 252 (Endocrinol Metab. 15): E189-E196, 1987.
35. Wolfe, R. R. and J. H. F. Shaw. Glucose and FFA kinetics in sepsis: role of glucagon and sympathetic nervous system activity. Am. J. Physiol 248 (Endocrinol. Metab. 11): E236-E243, 1985.
36. 2 enrichment. J. Appl. Physiol. 56:230-234, 1984.